Federal Register / Vol. 82, No. 206 / Thursday, October 26, 2017 / Notices 49609 

1See 82 FR 40154 (August 24, 2017). 

public comment period for the proposal 

by 30 days, so that the comment period 

ends on November 23, 2017. 

DATES: The proposed collection of 

information is amended effective 

October 18, 2017 and the public 

comment period shall terminate on 

November 23, 2017. 

FOR FURTHER INFORMATION CONTACT: A 

copy of the PRA OMB submission, 

including the proposed reporting form 

and instructions, supporting statement, 

and other documentation will be placed 

into OMB’s public docket files, once 

approved. These documents will also be 

made available on the Board’s public 

Web site at: http://

www.federalreserve.gov/apps/ 

reportforms/review.aspx or may be 

requested from the agency clearance 

officer, whose name appears below. 

Federal Reserve Board Clearance 

Officer—Nuha Elmaghrabi—Office of 

the Chief Data Officer, Board of 

Governors of the Federal Reserve 

System, Washington, DC 20551, (202) 

452–3829. Telecommunications Device 

for the Deaf (TDD) users may contact 

(202) 263–4869, Board of Governors of 

the Federal Reserve System, 

Washington, DC 20551. 

SUPPLEMENTARY INFORMATION: On August 

24, 2017, the Board invited public 

comment on a proposal that would 

extend for three years the FR Y–15 and 

make certain revisions to the report (FR 

Y–15 proposal). As revised, the report 

would include Mexican pesos in total 

payments activity rather than as a 

memorandum item; add securities 

brokers to the definition of financial 

institutions; expressly include 

derivative transactions where a clearing 

member bank guarantees the 

performance of a client to a central 

counterparty; and, specify how certain 

cleared derivatives transactions are 

reported.1 As initially proposed, these 

revisions to the FR Y–15 would have 

been effective for reports reflecting a 

December 31, 2017, as-of date. The 

comment period for the FR Y–15 

proposal was previously scheduled to 

end on October 23, 2017. 

The Board has received feedback that 

additional time may be required for 

affected banking organizations to 

analyze the impact of, and to provide 

comments on, the FR Y–15 changes 

being proposed. 

In response to the feedback, this 

notice hereby reopens the public 

comment period for the FR Y–15 

proposal by 30 days, with comments 

due November 23, 2017, to provide 

additional time for comment. 

This notice also amends the proposed 

implementation date of the FR Y–15 

proposal such that the proposed 

changes would be effective for reports 

reflecting the March 31, 2018, as-of date. 

This revision would provide 

respondents with an additional 90 days 

to prepare their systems to reflect any 

changes to the FR Y–15 that the Board 

may adopt after reviewing the 

comments received. 

Board of Governors of the Federal Reserve 

System, October 23, 2017. 

Ann E. Misback, 

Secretary of the Board. 

[FR Doc. 2017–23271 Filed 10–25–17; 8:45 am] 

BILLING CODE 6210–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Advisory Council for the Elimination of 

Tuberculosis Meeting 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of meeting. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, the 

Centers for Disease Control and 

Prevention (CDC) announces the 

following meeting of the Advisory 

Council for the Elimination of 

Tuberculosis (ACET). This meeting is 

open to the public, limited only by 100 

room seating and 100 ports for audio 

phone lines. Time will be available for 

public comment. Comments should be 

submitted in writing by email to the 

contact person listed below. The 

deadline for receipt is Monday, 

December 4, 2017. Persons who desire 

to make an oral statement, may request 

it at the time of the public comment 

period on December 12, 2017 at 11:40 

a.m. EST. This meeting is also 

accessible by teleconference: 1–877– 

927–1433 and participant passcode: 

12016435. 

DATES: The meeting will be held on 

December 11, 2017, 8:30 a.m. to 4:30 

p.m., EST and December 12, 2017, 8:30 

a.m. to 12:00 p.m., EST. 

ADDRESSES: CDC Corporate Square 

Campus, 8 Corporate Square Boulevard, 

Atlanta, Georgia 30329. 

FOR FURTHER INFORMATION CONTACT: 

Margie Scott-Cseh, Committee 

Management Specialist, CDC, 1600 

Clifton Road NE., Mailstop: E–07, 

Atlanta, Georgia 30329, telephone (404) 

639–8317; zkr7@cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Purpose: This Council advises and 

makes recommendations to the 

Secretary of Health and Human 

Services, the Assistant Secretary for 

Health, and the Director, CDC, regarding 

the elimination of tuberculosis. 

Specifically, the Council makes 

recommendations regarding policies, 

strategies, objectives, and priorities; 

addresses the development and 

application of new technologies; and 

reviews the extent to which progress has 

been made toward eliminating 

tuberculosis. 

Matters To Be Considered: The agenda 

will include discussions on (1) Update 

on preliminary tuberculosis funding 

formula; (2) Update on whole genome 

sequencing data sharing plan; (3) 

Update on three-month Isoniazid/ 

Rifapentine Regimen (3HP) guidelines; 

and (4) Updates from ACET 

workgroups. Agenda items are subject to 

change as priorities dictate. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Claudette Grant, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention. 

[FR Doc. 2017–23335 Filed 10–25–17; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Board of Scientific Counselors, Office 

of Infectious Diseases (BSC, OID) 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of meeting. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, the 

Centers for Disease Control and 

Prevention (CDC), announces the 

following meeting for the Board of 

Scientific Counselors, Office of 

Infectious Diseases (BSC, OID). This 

meeting is open to the public, limited 

only by the space available; the meeting 

room will accommodate up to 100 

people. The public is also welcome to 

listen to the meeting by telephone, 

limited only by the number of ports 


ethrower on DSK3G9T082PROD with NOTICES